Study guides / Series 79: Investment Banking Representative / Going-private deals & takeover defenses
Going-private deals & takeover defenses
Series 79: Investment Banking Representative · quick review
When Rule 13e-3 applies to an insider buyout and what Schedule 13E-3 must say, plus the main defenses a buyer meets: rights plans, staggered boards and state takeover statutes.
The rules
- Rule 13e-3 transaction: an issuer or affiliate buys its equity, makes a tender offer, or solicits votes on a merger, reclassification, asset sale to an affiliate or reverse split that cashes out fractions, and the step is likely or intended to have one of two effects: the class becomes eligible to deregister or suspend reporting (usually under 300 holders of record), or it loses its exchange listing and quotation.
- Schedule 13E-3: filed with exhibits and amended promptly for material changes. Holders get a summary term sheet, a prominent Special Factors section at the front (purposes, alternatives, reasons and effects; fairness; outside reports) and a legend saying the SEC hasn’t approved the deal or passed on its fairness.
- Fairness statement (Item 1014): the filer must say whether it reasonably believes the deal is fair or unfair to unaffiliated holders and explain the material factors in detail, such as current and historical prices, net book value, going-concern and liquidation value, prior purchase prices, outside reports and firm offers in the past 2 years.
- Process disclosures: the filer states whether a majority of unaffiliated holders must approve, whether non-employee directors retained an unaffiliated representative, and whether a majority of those directors approved. Any outside report, opinion or appraisal materially related to the deal is described under Item 1015 and made available for inspection.
- Timing and exceptions: disclosure must reach holders at least 20 days before the purchase, vote or consent. Exceptions include a second-step deal within 1 year after a tender offer by a bidder that became an affiliate, if holders get at least the highest tender price and the plan was disclosed, and deals where holders get only equity with substantially similar rights.
- Shareholder rights plan (poison pill): board-issued rights that let holders other than the bidder buy stock at a steep discount once someone crosses an ownership trigger, heavily diluting the bidder. No shareholder vote is needed, and the board can redeem the rights, so a bidder must negotiate with the board or replace it. Delaware upheld pills in Moran (1985).
- Staggered board: directors sit in up to 3 classes, with one class elected each year, so a bidder usually needs two annual meetings to win a majority. In Delaware, unless the charter says otherwise, classified directors can be removed only for cause. Paired with a pill, it’s a strong defense.
- Control share statutes: state laws that deny voting rights to shares bought past set levels unless disinterested holders vote to restore them. Indiana’s law uses 20%, 33⅓% and 50%, and the Supreme Court upheld it in CTS v. Dynamics (1987).
- Business combination statutes: Delaware Section 203 bars a merger with a 15% holder for 3 years unless the board approved first, the holder reached 85% in the same transaction, or the board and 66⅔% of the other holders approve. A company can opt out.
- Court review: under Unocal (Del. 1985), a board’s defensive steps must be a reasonable, proportionate response to a threat it reasonably identifies. Once the company is for sale, Revlon shifts the focus to value for shareholders.
Common traps
- Rule 13e-3 needs the issuer or an affiliate on the buying side. A cash merger with an unrelated buyer usually isn’t covered, even though the stock delists.
- A filer can’t avoid the fairness statement by saying it has no belief either way.
- The fairness statement speaks to unaffiliated holders, not all holders.
- A control share statute limits voting rights; a business combination statute delays a merger. Section 203 is the second kind.
- A pill doesn’t block a bid outright. It makes crossing the trigger costly until the board redeems it.
How it's tested
Whether a deal is a Rule 13e-3 transaction, what Schedule 13E-3 adds, and telling each takeover defense and state statute apart.
Practise it
The full lesson, worked examples and practice questions are in Tickmark, where every answer choice is explained.
Open the full lesson